Top 40: WHO Publishes Research Priorities on Antimicrobial Resistance 22/06/2023 Kerry Cullinan The World Health Organization (WHO) has published its first global research agenda to combat antimicrobial resistance (AMR) that outlines 40 research priorities. An estimated 4.95 million deaths were associated with bacterial AMR in 2019. AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to antimicrobial medicines making infections harder […] Continue reading -> Pharma Shares COVID-19 Voluntary Licensing Lessons Amid Debate Over Best Path to Access Pandemic Products 15/06/2023 Megha Kaveri One of the most intense debates in the pandemic accord negotiations is over how to fast-track the development and equitable rollout of vaccines and medicines, with pharmaceutical companies insisting that any infringement on intellectual property (IP) rights will stifle innovation and that voluntary arrangements are the way forward. A recent event to showcase voluntary licensing […] Continue reading -> How Global Action Can Meet Local Needs in Emerging Outbreaks 09/06/2023 Paul Adepoju More R&D into already known emerging disease threats, from Mpox to Lassa fever would go a long way to both bolster developing countries’ preparedness as well as protecting the world, experts argue. Member state negotiations resume next week over a draft WHO convention on pandemic prevention, preparedness and response – which is supposed to be […] Continue reading -> New ‘Lab’ Aims to Leverage Digital Tools for Health Policy Making 03/06/2023 Maayan Hoffman A new collaboration called the “Global Health Policy Lab” (GHPL) aims to develop digital tools that strengthen the available global capacity to identify, benchmark, disseminate and assess the impact of relevant health laws and policies within the field of global health. The lab, a partnership between the Harvard Health Systems Innovation Lab and the Charité […] Continue reading -> Sharp Condemnation of Sackler Family’s Immunity from Opioid Lawsuits 01/06/2023 Megha Kaveri A US court’s decision to provide legal immunity to a family that made billions by marketing opioids as “non addictive painkillers” in exchange for a $6 billion settlement has evoked sharp criticism from politicians and health advocates. The US Court of Appeals ruled on Tuesday that the Sackler family will enjoy protection from current and […] Continue reading -> WHA Approves Resolutions on Rehabilitation; Fake Medicines and Disability 29/05/2023 Disha Shetty The World Health Assembly (WHA) on Monday greenlit a slew of decisions and resolutions that aim to bring another one billion people under the coverage of universal health coverage (UHC), as the 76th WHA session drew closer to its end. The plan is the bedrock of WHO’s vision to deliver on so-called “triple billion targets” […] Continue reading -> World Resilience Summit Galvanises Public-Private Solutions to Feed into Pandemic Accord Negotiations 25/05/2023 Kerry Cullinan GENEVA – Global health conversations are much deeper at present because everyone has been affected by COVID-19 – and this opens up the possibility of building an “all-of-society” approach before the next pandemic, said Sylvie Brand, the World Health Organization’s (WHO) Director of Epidemic and Pandemic Preparedness and Prevention. “We have seen during this pandemic […] Continue reading -> Exclusive: Updated Pandemic Accord Draft Sees Watered Down Text on Publicly-Funded R&D; Pathogen Access and ‘Benefit Sharing’ Linkage Remain 24/05/2023 Elaine Ruth Fletcher A new “Zero+” version of a proposed World Health Organization pandemic accord being negotiated by member states has dropped previously strong language that conditioned use of public R&D funds to private sector commitments to price transparency and tech transfer of end products, among other measuress. However, the updated draft text, obtained by Health Policy Watch, […] Continue reading -> US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pharma Shares COVID-19 Voluntary Licensing Lessons Amid Debate Over Best Path to Access Pandemic Products 15/06/2023 Megha Kaveri One of the most intense debates in the pandemic accord negotiations is over how to fast-track the development and equitable rollout of vaccines and medicines, with pharmaceutical companies insisting that any infringement on intellectual property (IP) rights will stifle innovation and that voluntary arrangements are the way forward. A recent event to showcase voluntary licensing […] Continue reading -> How Global Action Can Meet Local Needs in Emerging Outbreaks 09/06/2023 Paul Adepoju More R&D into already known emerging disease threats, from Mpox to Lassa fever would go a long way to both bolster developing countries’ preparedness as well as protecting the world, experts argue. Member state negotiations resume next week over a draft WHO convention on pandemic prevention, preparedness and response – which is supposed to be […] Continue reading -> New ‘Lab’ Aims to Leverage Digital Tools for Health Policy Making 03/06/2023 Maayan Hoffman A new collaboration called the “Global Health Policy Lab” (GHPL) aims to develop digital tools that strengthen the available global capacity to identify, benchmark, disseminate and assess the impact of relevant health laws and policies within the field of global health. The lab, a partnership between the Harvard Health Systems Innovation Lab and the Charité […] Continue reading -> Sharp Condemnation of Sackler Family’s Immunity from Opioid Lawsuits 01/06/2023 Megha Kaveri A US court’s decision to provide legal immunity to a family that made billions by marketing opioids as “non addictive painkillers” in exchange for a $6 billion settlement has evoked sharp criticism from politicians and health advocates. The US Court of Appeals ruled on Tuesday that the Sackler family will enjoy protection from current and […] Continue reading -> WHA Approves Resolutions on Rehabilitation; Fake Medicines and Disability 29/05/2023 Disha Shetty The World Health Assembly (WHA) on Monday greenlit a slew of decisions and resolutions that aim to bring another one billion people under the coverage of universal health coverage (UHC), as the 76th WHA session drew closer to its end. The plan is the bedrock of WHO’s vision to deliver on so-called “triple billion targets” […] Continue reading -> World Resilience Summit Galvanises Public-Private Solutions to Feed into Pandemic Accord Negotiations 25/05/2023 Kerry Cullinan GENEVA – Global health conversations are much deeper at present because everyone has been affected by COVID-19 – and this opens up the possibility of building an “all-of-society” approach before the next pandemic, said Sylvie Brand, the World Health Organization’s (WHO) Director of Epidemic and Pandemic Preparedness and Prevention. “We have seen during this pandemic […] Continue reading -> Exclusive: Updated Pandemic Accord Draft Sees Watered Down Text on Publicly-Funded R&D; Pathogen Access and ‘Benefit Sharing’ Linkage Remain 24/05/2023 Elaine Ruth Fletcher A new “Zero+” version of a proposed World Health Organization pandemic accord being negotiated by member states has dropped previously strong language that conditioned use of public R&D funds to private sector commitments to price transparency and tech transfer of end products, among other measuress. However, the updated draft text, obtained by Health Policy Watch, […] Continue reading -> US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
How Global Action Can Meet Local Needs in Emerging Outbreaks 09/06/2023 Paul Adepoju More R&D into already known emerging disease threats, from Mpox to Lassa fever would go a long way to both bolster developing countries’ preparedness as well as protecting the world, experts argue. Member state negotiations resume next week over a draft WHO convention on pandemic prevention, preparedness and response – which is supposed to be […] Continue reading -> New ‘Lab’ Aims to Leverage Digital Tools for Health Policy Making 03/06/2023 Maayan Hoffman A new collaboration called the “Global Health Policy Lab” (GHPL) aims to develop digital tools that strengthen the available global capacity to identify, benchmark, disseminate and assess the impact of relevant health laws and policies within the field of global health. The lab, a partnership between the Harvard Health Systems Innovation Lab and the Charité […] Continue reading -> Sharp Condemnation of Sackler Family’s Immunity from Opioid Lawsuits 01/06/2023 Megha Kaveri A US court’s decision to provide legal immunity to a family that made billions by marketing opioids as “non addictive painkillers” in exchange for a $6 billion settlement has evoked sharp criticism from politicians and health advocates. The US Court of Appeals ruled on Tuesday that the Sackler family will enjoy protection from current and […] Continue reading -> WHA Approves Resolutions on Rehabilitation; Fake Medicines and Disability 29/05/2023 Disha Shetty The World Health Assembly (WHA) on Monday greenlit a slew of decisions and resolutions that aim to bring another one billion people under the coverage of universal health coverage (UHC), as the 76th WHA session drew closer to its end. The plan is the bedrock of WHO’s vision to deliver on so-called “triple billion targets” […] Continue reading -> World Resilience Summit Galvanises Public-Private Solutions to Feed into Pandemic Accord Negotiations 25/05/2023 Kerry Cullinan GENEVA – Global health conversations are much deeper at present because everyone has been affected by COVID-19 – and this opens up the possibility of building an “all-of-society” approach before the next pandemic, said Sylvie Brand, the World Health Organization’s (WHO) Director of Epidemic and Pandemic Preparedness and Prevention. “We have seen during this pandemic […] Continue reading -> Exclusive: Updated Pandemic Accord Draft Sees Watered Down Text on Publicly-Funded R&D; Pathogen Access and ‘Benefit Sharing’ Linkage Remain 24/05/2023 Elaine Ruth Fletcher A new “Zero+” version of a proposed World Health Organization pandemic accord being negotiated by member states has dropped previously strong language that conditioned use of public R&D funds to private sector commitments to price transparency and tech transfer of end products, among other measuress. However, the updated draft text, obtained by Health Policy Watch, […] Continue reading -> US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New ‘Lab’ Aims to Leverage Digital Tools for Health Policy Making 03/06/2023 Maayan Hoffman A new collaboration called the “Global Health Policy Lab” (GHPL) aims to develop digital tools that strengthen the available global capacity to identify, benchmark, disseminate and assess the impact of relevant health laws and policies within the field of global health. The lab, a partnership between the Harvard Health Systems Innovation Lab and the Charité […] Continue reading -> Sharp Condemnation of Sackler Family’s Immunity from Opioid Lawsuits 01/06/2023 Megha Kaveri A US court’s decision to provide legal immunity to a family that made billions by marketing opioids as “non addictive painkillers” in exchange for a $6 billion settlement has evoked sharp criticism from politicians and health advocates. The US Court of Appeals ruled on Tuesday that the Sackler family will enjoy protection from current and […] Continue reading -> WHA Approves Resolutions on Rehabilitation; Fake Medicines and Disability 29/05/2023 Disha Shetty The World Health Assembly (WHA) on Monday greenlit a slew of decisions and resolutions that aim to bring another one billion people under the coverage of universal health coverage (UHC), as the 76th WHA session drew closer to its end. The plan is the bedrock of WHO’s vision to deliver on so-called “triple billion targets” […] Continue reading -> World Resilience Summit Galvanises Public-Private Solutions to Feed into Pandemic Accord Negotiations 25/05/2023 Kerry Cullinan GENEVA – Global health conversations are much deeper at present because everyone has been affected by COVID-19 – and this opens up the possibility of building an “all-of-society” approach before the next pandemic, said Sylvie Brand, the World Health Organization’s (WHO) Director of Epidemic and Pandemic Preparedness and Prevention. “We have seen during this pandemic […] Continue reading -> Exclusive: Updated Pandemic Accord Draft Sees Watered Down Text on Publicly-Funded R&D; Pathogen Access and ‘Benefit Sharing’ Linkage Remain 24/05/2023 Elaine Ruth Fletcher A new “Zero+” version of a proposed World Health Organization pandemic accord being negotiated by member states has dropped previously strong language that conditioned use of public R&D funds to private sector commitments to price transparency and tech transfer of end products, among other measuress. However, the updated draft text, obtained by Health Policy Watch, […] Continue reading -> US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sharp Condemnation of Sackler Family’s Immunity from Opioid Lawsuits 01/06/2023 Megha Kaveri A US court’s decision to provide legal immunity to a family that made billions by marketing opioids as “non addictive painkillers” in exchange for a $6 billion settlement has evoked sharp criticism from politicians and health advocates. The US Court of Appeals ruled on Tuesday that the Sackler family will enjoy protection from current and […] Continue reading -> WHA Approves Resolutions on Rehabilitation; Fake Medicines and Disability 29/05/2023 Disha Shetty The World Health Assembly (WHA) on Monday greenlit a slew of decisions and resolutions that aim to bring another one billion people under the coverage of universal health coverage (UHC), as the 76th WHA session drew closer to its end. The plan is the bedrock of WHO’s vision to deliver on so-called “triple billion targets” […] Continue reading -> World Resilience Summit Galvanises Public-Private Solutions to Feed into Pandemic Accord Negotiations 25/05/2023 Kerry Cullinan GENEVA – Global health conversations are much deeper at present because everyone has been affected by COVID-19 – and this opens up the possibility of building an “all-of-society” approach before the next pandemic, said Sylvie Brand, the World Health Organization’s (WHO) Director of Epidemic and Pandemic Preparedness and Prevention. “We have seen during this pandemic […] Continue reading -> Exclusive: Updated Pandemic Accord Draft Sees Watered Down Text on Publicly-Funded R&D; Pathogen Access and ‘Benefit Sharing’ Linkage Remain 24/05/2023 Elaine Ruth Fletcher A new “Zero+” version of a proposed World Health Organization pandemic accord being negotiated by member states has dropped previously strong language that conditioned use of public R&D funds to private sector commitments to price transparency and tech transfer of end products, among other measuress. However, the updated draft text, obtained by Health Policy Watch, […] Continue reading -> US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHA Approves Resolutions on Rehabilitation; Fake Medicines and Disability 29/05/2023 Disha Shetty The World Health Assembly (WHA) on Monday greenlit a slew of decisions and resolutions that aim to bring another one billion people under the coverage of universal health coverage (UHC), as the 76th WHA session drew closer to its end. The plan is the bedrock of WHO’s vision to deliver on so-called “triple billion targets” […] Continue reading -> World Resilience Summit Galvanises Public-Private Solutions to Feed into Pandemic Accord Negotiations 25/05/2023 Kerry Cullinan GENEVA – Global health conversations are much deeper at present because everyone has been affected by COVID-19 – and this opens up the possibility of building an “all-of-society” approach before the next pandemic, said Sylvie Brand, the World Health Organization’s (WHO) Director of Epidemic and Pandemic Preparedness and Prevention. “We have seen during this pandemic […] Continue reading -> Exclusive: Updated Pandemic Accord Draft Sees Watered Down Text on Publicly-Funded R&D; Pathogen Access and ‘Benefit Sharing’ Linkage Remain 24/05/2023 Elaine Ruth Fletcher A new “Zero+” version of a proposed World Health Organization pandemic accord being negotiated by member states has dropped previously strong language that conditioned use of public R&D funds to private sector commitments to price transparency and tech transfer of end products, among other measuress. However, the updated draft text, obtained by Health Policy Watch, […] Continue reading -> US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Resilience Summit Galvanises Public-Private Solutions to Feed into Pandemic Accord Negotiations 25/05/2023 Kerry Cullinan GENEVA – Global health conversations are much deeper at present because everyone has been affected by COVID-19 – and this opens up the possibility of building an “all-of-society” approach before the next pandemic, said Sylvie Brand, the World Health Organization’s (WHO) Director of Epidemic and Pandemic Preparedness and Prevention. “We have seen during this pandemic […] Continue reading -> Exclusive: Updated Pandemic Accord Draft Sees Watered Down Text on Publicly-Funded R&D; Pathogen Access and ‘Benefit Sharing’ Linkage Remain 24/05/2023 Elaine Ruth Fletcher A new “Zero+” version of a proposed World Health Organization pandemic accord being negotiated by member states has dropped previously strong language that conditioned use of public R&D funds to private sector commitments to price transparency and tech transfer of end products, among other measuress. However, the updated draft text, obtained by Health Policy Watch, […] Continue reading -> US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Exclusive: Updated Pandemic Accord Draft Sees Watered Down Text on Publicly-Funded R&D; Pathogen Access and ‘Benefit Sharing’ Linkage Remain 24/05/2023 Elaine Ruth Fletcher A new “Zero+” version of a proposed World Health Organization pandemic accord being negotiated by member states has dropped previously strong language that conditioned use of public R&D funds to private sector commitments to price transparency and tech transfer of end products, among other measuress. However, the updated draft text, obtained by Health Policy Watch, […] Continue reading -> US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US FDA Approves First-Ever RSV Vaccine 04/05/2023 Megha Kaveri The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading -> Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Following Kenya, Malawi Appears Ready to Ratify the African Medicines Agency Treaty 01/05/2023 Josephine Chinele BLANTYRE, Malawi – Key Malawian key stakeholders have given the nod for the country to ratify the African Medicines Agency (AMA) treaty, the country’s Ministry of Foreign Affairs and International Cooperation has confirmed. The AMA is being established as a specialised agency of the African Union (AU) dedicated to improving access to quality, safe and […] Continue reading -> Posts navigation Older postsNewer posts